May 13, 2015

Blood Pressure Evaluation During Early Phase Trials

Daniel B. Goodman, MD, Michael A. Weber, MD; 3 Nov 2014

More attention is being paid to blood pressure (BP) effects in new chemical entities under development for non-hypertension indications, especially when these are not anticipated and not thoroughly defined during drug development.

Mar 25, 2015

ECHO Inter/Intra-Reader Variability

Goodman DB and Voloshko P; 4 Sep 2014

This report by Daniel B. Goodman, MD, and Polina Voloshko, MD, of BioTelemetry Research, formerly Cardiocore, describes the inter-reader and intra-reader variability in a central reference laboratory for 8 ECHO Cardiogram (ECHO) parameters.

Aug 3, 2014

Effect of Anagrelide on Cardiac Repolarization in Healthy Volunteers: A Randomized, Double-Blind, Placebo- and Positive-Controlled, Thorough QT Study

Troy S et al; 3 Aug 2014
Dec 23, 2013

Loxapine Delivered as a Thermally Generated Aerosol Does Not Prolong QTc in a Thorough QT/QTc Study in Healthy Subjects

Spyker DA, Voloshko P, Heyman ER, Cassella JV; 23 Dec 2013
Jun 5, 2013

Association of Segmental Wall Motion Abnormalities Occurring During Hemodialysis with Post-Dialysis Fatigue

Dubin RF, et al; 5 Jun 2013
Apr 23, 2012

Major Cardiotoxicity Biomarkers During Oncology Development

Voloshko P, McPhillips J; 23 Apr 2012



May 13-15, 2015

Heart Rhythm 2015

36th Annual Scientific Sessions
Boston Convention & Exhibition Center
Booth 819